The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-Benzyl-N4-((1r,3r)-3-hydroxycyclobutyl)-N2-methylpyridine-2,4-dicarboxamide ID: ALA4876311
PubChem CID: 132167406
Max Phase: Preclinical
Molecular Formula: C19H21N3O3
Molecular Weight: 339.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)c1cc(C(=O)N[C@H]2C[C@H](O)C2)cc(Cc2ccccc2)n1
Standard InChI: InChI=1S/C19H21N3O3/c1-20-19(25)17-9-13(18(24)22-15-10-16(23)11-15)8-14(21-17)7-12-5-3-2-4-6-12/h2-6,8-9,15-16,23H,7,10-11H2,1H3,(H,20,25)(H,22,24)/t15-,16-
Standard InChI Key: FQRNJZDJWMGBEX-WKILWMFISA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
5.0343 -27.5245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3290 -27.1118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3290 -26.2946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0367 -25.8860 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6213 -25.8860 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7444 -26.2946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6237 -27.5245 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6237 -28.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3290 -28.7461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0343 -28.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9166 -28.7513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2083 -28.3437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2101 -27.5275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5026 -27.1200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7945 -27.5297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7983 -28.3511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5064 -28.7549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7414 -28.7513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7402 -29.5685 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4497 -28.3437 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1568 -28.7534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3660 -29.5398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1557 -29.3294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9453 -28.5397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8628 -29.7390 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
3 5 2 0
4 6 1 0
7 8 2 0
8 9 1 0
9 10 2 0
8 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
2 7 1 0
1 10 1 0
10 18 1 0
18 19 2 0
18 20 1 0
21 20 1 6
21 22 1 0
22 23 1 0
23 24 1 0
24 21 1 0
23 25 1 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 339.40Molecular Weight (Monoisotopic): 339.1583AlogP: 1.29#Rotatable Bonds: 5Polar Surface Area: 91.32Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.60CX Basic pKa: 0.37CX LogP: 0.63CX LogD: 0.63Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.77Np Likeness Score: -0.40
References 1. Harrison LA, Atkinson SJ, Bassil A, Chung CW, Grandi P, Gray JRJ, Levernier E, Lewis A, Lugo D, Messenger C, Michon AM, Mitchell DJ, Preston A, Prinjha RK, Rioja I, Seal JT, Taylor S, Wall ID, Watson RJ, Woolven JM, Demont EH.. (2021) Identification of a Series of N -Methylpyridine-2-carboxamides as Potent and Selective Inhibitors of the Second Bromodomain (BD2) of the Bromo and Extra Terminal Domain (BET) Proteins., 64 (15.0): [PMID:34232650 ] [10.1021/acs.jmedchem.0c02155 ]